Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

The Medicines Company (MDCO)

-NasdaqGS

32.99 Down 0.33(0.99%) May 24, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 155,753   159,490   136,786   135,702  
Cost of Revenue56,714  52,228  43,767  42,681  
Gross Profit 99,039   107,262   93,019   93,021  
Operating Expenses
Research Development58,196  26,147  34,536  32,962  
Selling General and Administrative63,482  44,704  43,396  40,467  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (22,639) 36,411   15,087   19,592  
Income from Continuing Operations
Total Other Income/Expenses Net3,948  3,927  3,954  3,197  
Earnings Before Interest And Taxes(18,691)40,338  19,041  22,789  
Interest Expense3,674  3,616  3,605  784  
Income Before Tax(22,365)36,722  15,436  22,005  
Income Tax Expense(10,759)16,141  6,172  8,251  
Minority Interest33  82  1  1  
Net Income From Continuing Ops(11,573)20,663  9,265  13,755  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (11,573) 20,663   9,265   13,755  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (11,573) 20,663   9,265   13,755  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.